GLENMEDE TRUST CO NA - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2020$12,000
+20.0%
1400.0%0.00%
Q2 2020$10,000
-92.5%
140
-91.7%
0.00%
-100.0%
Q1 2020$134,0000.0%1,6840.0%0.00%0.0%
Q4 2019$134,000
+14.5%
1,684
+4.9%
0.00%0.0%
Q3 2019$117,000
+11600.0%
1,605
+10600.0%
0.00%
Q2 2019$1,000150.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders